Strategic Investment Advisors Abb Vie Inc. Transaction History

Strategic Investment Advisors

$909 Million
Q3 2024

A detailed history of Strategic Investment Advisors transactions in Abb Vie Inc. stock. As of the latest transaction made, Strategic Investment Advisors holds 10,162 shares of ABBV stock, worth $1.82 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

10,162

Previous 10,193 0.3%

Holding current value

$1.82 Million

Previous $1.75 Million 14.76%

% of portfolio

0.22%

Previous 0.21%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$163.84 - $199.33 $5,079 - $6,179	-31 Reduced 0.3%	10,162 $2.01 Million
Q2 2024 Jul 22, 2024	SELL	$154.79 - $180.76 $3,714 - $4,338	-24 Reduced 0.23%	10,193 $1.75 Million
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $7,191 - $8,194	45 Added 0.44%	10,217 $1.86 Million
Q4 2023 Jan 10, 2024	SELL	$137.6 - $154.97 $87,788 - $98,870	-638 Reduced 5.9%	10,172 $1.58 Million
Q3 2023 Oct 24, 2023	BUY	$133.59 - $154.65 $5,744 - $6,649	43 Added 0.4%	10,810 $1.61 Million
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $12,058 - $15,005	91 Added 0.85%	10,767 $1.45 Million
Q1 2023 Apr 27, 2023	SELL	$144.61 - $166.54 $87,633 - $100,923	-606 Reduced 5.37%	10,676 $1.7 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $553 - $663	-4 Reduced 0.04%	11,282 $0
Q3 2022 Oct 27, 2022	BUY	$134.21 - $153.93 $23,084 - $26,475	172 Added 1.55%	11,286 $1.52 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $4,266 - $5,423	-31 Reduced 0.28%	11,114 $1.7 Million
Q1 2022 Apr 28, 2022	SELL	$131.98 - $163.75 $369,807 - $458,827	-2,802 Reduced 20.09%	11,145 $1.81 Million
Q4 2021 Jan 26, 2022	BUY	$107.43 - $135.93 $61,127 - $77,344	569 Added 4.25%	13,947 $1.89 Million
Q3 2021 Oct 19, 2021	BUY	$106.4 - $120.78 $189,711 - $215,350	1,783 Added 15.38%	13,378 $1.44 Million
Q2 2021 Jul 22, 2021	BUY	$105.21 - $117.21 $341,722 - $380,698	3,248 Added 38.91%	11,595 $1.31 Million
Q1 2021 Apr 14, 2021	BUY	$102.3 - $112.62 $124,294 - $136,833	1,215 Added 17.04%	8,347 $903,000
Q4 2020 Jan 13, 2021	SELL	$80.49 - $108.67 $188,105 - $253,961	-2,337 Reduced 24.68%	7,132 $764,000
Q3 2020 Oct 14, 2020	SELL	$85.91 - $100.83 $100,858 - $118,374	-1,174 Reduced 11.03%	9,469 $828,000
Q2 2020 Aug 04, 2020	BUY	$73.37 - $98.18 $49,378 - $66,075	673 Added 6.75%	10,643 $1.05 Million
Q1 2020 Apr 13, 2020	BUY	$64.5 - $97.79 $28,057 - $42,538	435 Added 4.56%	9,970 $760,000
Q4 2019 Jan 23, 2020	BUY	$72.13 - $90.25 $22,648 - $28,338	314 Added 3.41%	9,535 $844,000
Q3 2019 Oct 25, 2019	BUY	$62.98 - $75.72 $73,497 - $88,365	1,167 Added 14.49%	9,221 $698,000
Q2 2019 Jul 23, 2019	BUY	$65.7 - $83.98 $145,985 - $186,603	2,222 Added 38.1%	8,054 $586,000
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $71,971 - $84,707	933 Added 19.04%	5,832 $470,000
Q4 2018 Feb 08, 2019	BUY	$77.85 - $96.01 $381,387 - $470,352	4,899 New	4,899 $452,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $317B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.

Account

Strategic Investment Advisors Abb Vie Inc. Transaction History